As filed with the Securities and Exchange Commission on January 16, 2015
Registration No. 333-
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM S-8
REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933
VIVEVE MEDICAL, INC.
(Exact name of registrant as specified in its charter)
Yukon Territory, Canada |
|
04-3153858 |
(State or Other Jurisdiction of Incorporation or Organization) |
|
(I.R.S. Employer Identification No.) |
150 Commercial Street
Sunnyvale, California
Telephone: (408) 530-1900
(Address, including zip code, and telephone number, including area code, of Registrant’s principal executive offices)
2013 Stock Option and Incentive Plan, as amended
(Full Title of the Plans)
Scott Durbin
Chief Financial Officer
Viveve Medical, Inc.
150 Commercial Street
Sunnyvale, California
Telephone: ( 408 ) 530-1900
(Name, address, including zip code, and telephone number, including area code, of agent for service)
Copies to :
Melanie Figueroa , Esq.
Richardson & Patel LLP
The Chrysler Building
405 Lexington Avenue, 49th Floor
New York, NY 10174
Telephone: (212) 931-8713
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, or a non-accelerated filer. See definition of “accelerated filer,” and “large accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):
Large accelerated filer ☐ |
Accelerated filer ☐ |
|
Non-accelerated filer ☐ |
Smaller reporting company ☑ |
|
(Do not check if a smaller reporting company) |
CALCULATION OF REGISTRATION FEE
Title of
|
Amount to be
|
Proposed
|
Proposed
|
Amount of
|
||||||||||||
Common Stock, no par value |
3,091,427 | $ | 0.48 | $ | 1,483,884.96 | $ | 172.43 |
(1) |
Pursuant to Rule 416(a) under the Securities Act of 1933, as amended, this registration statement shall also cover such indeterminate number of additional shares of the registrant’s common stock that become issuable by reason of any stock dividend, stock split, recapitalization or other similar transaction that increases the number of the registrant’s outstanding shares to be offered pursuant to the applicable plan described herein. |
(2) |
Estimated solely for purposes of calculating the registration fee in accordance with Rule 457(c) and (h)(1) of the Securities Act of 1933, as amended, based on the average of the bid and asked price for the registrant’s common stock as reported by the OTCQB of the OTC Markets Group Inc. on January 12, 2015. |
PART I
INFORMATION REQUIRED IN THE SECTION 10(a) PROSPECTUS
Information required in Part I of Form S-8 to be contained in a prospectus meeting the requirements of Section 10(a) of the Securities Act is not required to be filed with the Securities and Exchange Commission (the “ Commission ”) and is omitted from this registration statement in accordance with the explanatory note to Part I of Form S-8 and Rule 428(b)(1) under the Securities Act of 1933, as amended (the “ Securities Act ”).
PART II
INFORMATION REQUIRED IN THE REGISTRATION STATEMENT
Item 3. Incorporation of Documents by Reference.
The following documents, which have been filed by Viveve Medical, Inc. (the “ Registrant ”) with the Commission, are incorporated by reference in this registration statement:
(a) |
The Registrant’s latest Annual Report on Form 10-K, as filed with the Commission on March 31, 2014 and the amendment thereto as filed on April 30, 2014; |
(b) |
The Registrant’s Quarterly Reports on Form 10-Q as filed with the Commission on May 15, 2014, August 13, 2014 and November 14, 2014; |
(c) |
The Registrant’s Current Report on Form 8-K as filed with the Commission on April 18, 2014 (and the amendment thereto as filed on June 3, 2014), May 14, 2014, May 15, 2014, June 2, 2014, July 16, 2014, August 7, 2014, August 22, 2014, September 8, 2014, September 10, 2014, September 16, 2014, September 19, 2014, September 29, 2014 (and the amendment thereto filed on November 13, 2014), October 2, 2014 and October 3, 2014; |
(d) | The Registrant's Definitive Proxy Statement on Schedule 14A for its Annual and Special Meeting of Shareholders, filed with the Commission on August 11, 2014; and |
(e) |
The description of the common stock contained in the Registrant’s registration statement on Form 8-A filed with the Commission on November 25, 2008, including any amendment or report filed for the purpose of updating such description. |
All documents subsequently filed by the Registrant pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) prior to the filing of a post-effective amendment which indicates that all securities offered have been sold or which deregisters all securities then remaining unsold, shall be deemed to be incorporated by reference in this registration statement and to be a part hereof from the date of filing such documents.
Item 4. Description of Securities.
Not applicable.
Item 5. Interests of Named Experts and Counsel.
Not applicable.
Item 6. Indemnification of Directors and Officers.
The following summary is qualified in its entirety by reference to the complete text of the Yukon Business Corporations Act (the “ YBCA ”) and of By-Law No. 1 and By-Law No. 2 (collectively, the “ By-Laws ”), as amended, of the Registrant.
As permitted by Section 126 of the YBCA, the Registrant’s By-Laws provide that the Registrant shall indemnify its directors or officers, former directors or officers or persons who act or acted at the Registrant’s request as directors or officers of a body corporate of which the Registrant is or was a shareholder or creditor, and their heirs and legal representatives, against all costs, charges and expenses, including an amount paid to settle an action or satisfy a judgment, reasonably incurred by them in respect of any civil, criminal or administrative action or proceeding to which they are made party because they are or have been directors or officers of the Registrant or the body corporate, if:
(a) they acted honestly and in good faith with a view to the best interests of the corporation; and
(b) in the case of a criminal or administrative action or proceeding that is enforced by a monetary penalty, they had reasonable grounds for believing that their conduct was lawful.
The Registrant’s By-Laws further provide that no director shall be liable for the acts, receipts, neglects or defaults of any other director or officer or employee, or for joining in any receipt or other act for conformity, or for any loss, damage or expense happening to the Registrant through the insufficiency or deficiency of title to any property acquired for or on behalf of the Registrant, or for the insufficiency or deficiency of any security in or upon which any of the moneys of the Registrant shall be invested, or for any loss or damage arising from the bankruptcy, insolvency or tortious acts of any person with whom any of the moneys, securities or effects of the Registrant shall be deposited, or for any loss occasioned by any error of judgment or oversight on his part, or for any other loss, damage or misfortune whatever which shall happen in the execution of the duties of his office or in relation thereto, unless the same are occasioned by his own willful neglect or default; provided that nothing herein shall relieve any director or officer from the duty to act in accordance with the YBCA and the regulations thereunder or from liability for any breach thereof.
The Registrant’s By-Laws also provide that subject to the limitations contained in the YBCA, the Registrant may purchase and maintain insurance for the benefit of its directors and officers as the board of directors may from time to time determine. The Registrant has obtained on behalf of its directors and officers insurance protection against certain liabilities arising out of the discharge of their duties. The Registrant has also obtained insurance covering the Registrant against indemnification payments to its directors and officers for certain liabilities. However, to the extent such coverage is inadequate to cover claims against directors or officers, the Registrant may be required pursuant to its By-Laws to reimburse the directors or officers for the uninsured portion of such claims. In such an event, the Registrant’s indemnification obligations to its directors and officers could have a material negative impact on the Registrant’s financial condition and on shareholder equity.
Item 7. Exemption from Registration Claimed.
Not applicable.
Item 8. Exhibits.
The Exhibit Index immediately preceding the exhibits is incorporated herein by reference.
Item 9. Undertakings.
(a) |
The undersigned Registrant hereby undertakes: |
(1) |
To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement: |
i. |
To include any prospectus required by Section 10(a)(3) of the Securities Act; |
ii. |
To reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than 20% change in the maximum aggregate offering price set forth in the “Calculation of Registration Fee” table in the effective registration statement; and |
iii. |
To include any material information with respect to the plan of distribution not previously disclosed in the registration statement or any material change to such information in the registration statement; |
Provided, however , that paragraphs (a)(1)(i) and (a)(1)(ii) do not apply if this registration statement is on Form S-8, and the information required to be included in a post-effective amendment by those paragraphs is contained in reports filed with or furnished to the Commission by the Registrant pursuant to Section 13 or Section 15(d) of the Exchange Act that are incorporated by reference in this registration statement.
(2) |
That, for the purpose of determining any liability under the Securities Act, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. |
(3) |
To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering. |
(b) |
The undersigned Registrant hereby undertakes that, for purposes of determining any liability under the Securities Act, each filing of the Registrant's annual report pursuant to Section 13(a) or Section 15(d) of the Exchange Act (and, where applicable, each filing of an employee benefit plan's annual report pursuant to Section 15(d) of the Exchange Act) that is incorporated by reference in the registration statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. |
(c) |
Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the Registrant pursuant to the foregoing provisions, or otherwise, the Registrant has been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer or controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the Registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue. |
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Sunnyvale, State of California on the 16th day of January, 2015.
|
VIVEVE MEDICAL, INC. |
|
|
|
|
|
By: |
/s/ Patricia Scheller |
|
|
Patricia Scheller, Chief Executive Officer |
|
|
|
|
By: |
/s/ Scott Durbin |
|
|
Scott Durbin, Chief Financial Officer |
Pursuant to the requirements of the Securities Act of 1933, this registration statement has been signed by the following persons in the capacities and on the dates indicated:
Signature |
Name of Director |
Date |
||
|
|
|
|
|
/s/ Patricia Scheller * |
|
Patricia Scheller |
|
January 16, 2015 |
|
|
|
|
|
/s/ Brigitte Smith * |
|
Brigitte Smith |
|
January 16, 2015 |
|
|
|
||
/s/ Carl Simpson * |
|
Carl Simpson |
|
January 16, 2015 |
|
|
|
||
/s/ Daniel Janney * |
|
Daniel Janney |
|
January 16, 2015 |
|
|
|
||
/s/ Mark Colella * |
|
Mark Colella |
|
January 16, 2015 |
|
|
|
||
By: /s/ Patricia Scheller | ||||
Patricia Scheller, Attorney-in-Fact |
EXHIBIT INDEX
Exhibit No. |
|
Description of Exhibit |
|
|
|
4.1 | 2013 Stock Option and Incentive Plan (1) | |
4.2 | Amendment to 2013 Stock Option and Incentive Plan (2) | |
5.1 |
|
Opinion of Macdonald and Company* |
|
|
|
10.1 | Form of Non-Qualified Stock Option Grant* | |
10.2 | Form of Incentive Stock Option Grant* | |
23.1 |
|
Consent of Burr Pilger Mayer, Inc.* |
|
|
|
23.2 |
Consent of McGladrey LLP* |
|
23.3 |
|
Consent of Macdonald and Company (included in Exhibit 5.1) |
24.1 |
Power of Attorney* |
*Filed herewith
(1) Incorporated by reference to Exhibit 10.2 to the Company’s Current Report on Form 8-K (SEC File No. 001-11388) filed with the Commission by the Company on June 12, 2013.
(2) Incorporated by reference to Annex E to the Company’s Proxy Statement on Schedule 14A (SEC File No. 001-11388) filed with the Commission by the Company on August 11, 2014.
7
Exhibit 5.1
M ACDONALD & C OMPANY
Lawyers
Grant Macdonald, Q.C. Gareth C. Howells |
Suite 200, Financial Plaza |
|
204 Lambert Street |
|
Whitehorse, YT Y1A 3T2 |
Telephone: (867) 667-7885 |
|
Ext 239 |
|
Fax: (867) 667-7600 |
|
Email: ghowells@anton.yk.ca |
January 16, 2015
Viveve Medical, Inc.
150 Commercial Street
Sunnyvale, California
94086-5201
Dear Sirs/Mesdames:
Re: Registration Statement on Form S-8 Our File: 20140495
We have acted as Yukon Territory counsel on behalf of Viveve Medical, Inc., a corporation organized under the laws of the Yukon Territory, Canada (the "Company"), in connection with the registration of 3,091,427 shares of Common Stock of the Company (the "Common Stock") issuable under the Company’s 2013 Stock Option and Incentive Plan (the "Plan"). In connection therewith, we have examined, among other things, the Registration Statement on Form S-8 (the "Registration Statement") proposed to be filed by the Company with the Securities and Exchange Commission on or about January 16, 2015. We have also examined the proceedings and other actions taken by the Company in connection with the authorization of the shares of Common Stock issuable under the Plan and such other matters as we deemed necessary for purposes of rendering this opinion.
Based upon the foregoing, and in reliance thereon, we are of the opinion, as of the date hereof, that the shares of Common Stock issuable under the Plan, when issued, delivered and paid for in accordance with the Plan and in the manner described in the Registration Statement, will be validly issued, fully paid and non-assessable.
In rendering this opinion we express no opinion as to the laws of any jurisdiction other than the laws of the Yukon Territory.
MACDONALD & COMPANY
- 2
We hereby consent to the filing of this opinion as an exhibit to the Registration Statement. In giving this consent, we do not admit that we are within the category of persons whose consent is required under Section 7 of the Securities Act of 1933, as amended, or the General Rules and Regulations of the Securities and Exchange Commission.
Yours very truly,
MACDONALD & COMPANY
/s/ Gareth C. Howells
Gareth C. Howells
GCH/mls
Exhibit 10.1
VIVEVE MEDICAL, INC.
2013 STOCK OPTION AND INCENTIVE PLAN
NON-QUALIFIED STOCK OPTION AGREEMENT
THIS NON-QUALIFIED STOCK OPTION AGREEMENT (the “ Agreement ”) is made as of __________ __, 201_ , by and between Viveve Medical, Inc. , a Yukon Territory corporation (the “Grantor”), and ______________ , with an address at __________________________________ (“Optionee”).
WITNESSETH:
WHEREAS , the Viveve Medical, Inc. 2013 Stock Option and Incentive Plan (also referred to as the PLC Systems, Inc. 2013 Stock Option and Incentive Plan), as amended (the “ Plan ”), was adopted by the Board of Directors (the “ Board ”) and the stockholders of the Grantor to provide the Optionee with an opportunity to acquire or increase his proprietary interest in the business of the Grantor, and, through stock ownership, to possess an increased personal interest in its continued success and progress; and
WHEREAS , the Grantor desires to increase the incentive of the Optionee to exert his or her utmost efforts to improve the business and increase the assets of the Grantor as an investor in Viveve Medical, Inc.
NOW, THEREFORE , in consideration of the mutual covenants set forth in this Agreement and for other good and valuable consideration, the Grantor hereby grants the Optionee an option to purchase shares of common stock of the Grantor, no par value per share (the “ Common Stock ”), upon the following terms and conditions:
1. Option.
Pursuant to the Plan, the Grantor hereby grants to the Optionee a non-qualified stock option (the “ Option ”), not intended to qualify under Section 422 of the Internal Revenue Code of 1986, as amended, on the terms and conditions contained in the Plan, to purchase up to an aggregate _______ fully paid and non-assessable shares of Common Stock (the “ Option Shares ”).
2. Exercise Price.
The exercise price (“ Exercise Price ”) for the Option Shares shall be $__ per share. The Grantor shall pay all original issue or transfer taxes on the exercise of the Option and all other fees and expenses necessarily incurred by the Grantor in connection therewith.
3. Exercise of the Option.
(a) Except as otherwise set forth herein, the Option shall be exercisable as to those Option Shares that have vested in accordance with the provisions of subsection (b) below. The Option may be exercised in whole or in part, from time to time and at any time, as to those Option Shares that are vested until the Option lapses or terminates. If the Optionee’s exercise of the Option would require the Grantor to issue a fractional Option Share, the Grantor will not be required to issue such fractional Option Share but shall pay the Optionee in cash the value of such fractional Option Share. The right to purchase all unexercised Option Shares (whether or not vested) shall lapse and forever terminate on ____________ (the “ Termination Date ”).
(b) The right to exercise this Option and purchase of the Option Shares shall vest in the following manner: at a rate of ______ the number of Option Shares underlying the Option for each [month] of the Optionee’s continuous service to the Grantor.
4. Manner of Exercise.
(a) Subject to the vesting conditions set forth in Section 3(b) above and the terms of the Plan, this Option may be exercised in whole or in part at any time prior to the Termination Date by giving written notice to the Grantor, which written notice may be in the form of Exhibit A to this Agreement (the “ Exercise Notice ”), specifying the number of Option Shares to be purchased, accompanied by payment in full of the purchase price, in cash or by check. Payment in full or in part may be made at the election of the Optionee (i) in the form of Common Stock owned by the Optionee (based on the Fair Market Value (as that term is defined in the Plan) of the Common Stock on the trading day before the Option is exercised) which is not the subject of any pledge or security interest and which has been owned for more than 6 months and has been paid for within the meaning of the Rule 144 promulgated under the Securities Act of 1933, as amended (the “ Securities Act ”), or was purchased in the open market; (ii) by a “same day sale” commitment from the Optionee and a broker-dealer registered with FINRA to forward the Exercise Price directly to the Grantor; (iii) by cancellation of indebtedness of the Grantor to the Optionee; (iv) by waiver of consideration due to the Optionee for services rendered; or (v) by a combination of the foregoing, provided that the combined value of all cash and cash equivalents and the Fair Market Value of any Common Stock surrendered to the Grantor is at least equal to the Exercise Price. An Optionee shall have the right to dividends and other rights of a stockholder with respect to Option Shares purchased upon exercise of the Option at such time as the Optionee has given the Exercise Notice and has paid in full for such Option Shares and has satisfied such conditions that may be imposed by the Grantor with respect to the withholding of taxes.
(b) In the event that any person or persons other than the Optionee attempt to exercise the Option, the Exercise Notice shall be accompanied by proof, satisfactory to the Grantor, of the right of such person or persons, under the Plan, to effect such exercise.
5. Cessation of Service .
(a) In the event that the service of the Optionee shall terminate (otherwise than by reason of the Optionee’s death or disability, or for cause), the Option may be exercised (if and to the extent that the Optionee was entitled to do so at the date of termination of the Optionee’s service) at any time within ninety days after such termination, but in no event after the Termination Date. The Option shall not be exercisable by the Optionee following termination of the Optionee’s employment or service for cause. "Termination for cause" shall mean dismissal for dishonesty, conviction or confession of a crime punishable by law (except minor violations), fraud, misconduct or disclosure of confidential information. If the service of the Optionee shall be suspended pending an investigation of whether or not the Optionee shall be terminated for cause, all of the Optionee’s rights connected to the Option shall be suspended during the period of investigation.
(b) In the event that the service of the Optionee shall terminate by reason of death or disability, the Option may be exercised (if and to the extent that the Optionee was entitled to do so at the date of termination of the Optionee’s service) at any time with three hundred and sixty days days after such termination, but in no event after the Termination Date.
6. Transfer of the Option.
Except as specifically provided in Section 5(b) of the Plan and this Agreement, the Optionee may not give, grant, sell, exchange, transfer legal title, pledge, assign or otherwise encumber or dispose of the Option herein granted or any interest therein. Any attempt to transfer, assign, pledge or otherwise dispose of, or to subject to execution, attachment or similar process, the Option contrary to the provisions hereof shall be void and ineffective and shall give no right to the purported transferee. Notwithstanding the foregoing, the Optionee may transfer this Option to members of Optionee’s immediate family, to trusts for the benefit of such family members, or to partnerships in which such family members are the only partners, provided that the transferee agrees in writing with the Company to be bound by all of the terms and conditions of the Plan and this Option.
7. Stock as Investment.
By accepting the Option herein granted, the Optionee agrees for itself and its beneficiaries that, unless the Option Shares are sold pursuant to an effective registration statement under the Securities Act or an exemption from registration, all Option Shares purchased hereunder shall be acquired for investment purposes only and not for sale or distribution, and upon the issuance of any or all of the Option Shares issuable under the Option, the Optionee, or his heirs or legatees receiving such Option Shares, shall deliver to the Grantor a representation in writing, that unless such Option Shares have been registered for resale they are being acquired in good faith for investment purposes only and not for sale or distribution. Grantor may place a “stop transfer” order with respect to such Option Shares with its transfer agent and place an appropriate restrictive legend on the stock certificate evidencing such Shares.
8. Restriction on Issuance of Option Shares.
The Grantor shall not be required to issue or deliver any certificate for Option Shares purchased upon the exercise of the Option unless (a) the issuance of such Option Shares has been registered with the Securities and Exchange Commission under the Securities Act, or counsel to the Grantor shall have given an opinion that such registration is not required; (b) approval, to the extent required, shall have been obtained from any state regulatory body having jurisdiction thereof; and (c) permission for the listing of such shares shall have been given by any national securities exchange on which the Common Stock of the Grantor is at the time of issuance listed.
9. Adjustment on Changes in Capitalization.
(a) In the event of changes in the outstanding Common Stock of the Grantor by reason of stock dividends, stock splits, reverse stock splits, recapitalizations, mergers, consolidations, combinations or exchanges of shares, separations, reorganizations or liquidations, reclassification or other distribution, the number of Option Shares as to which the Option may be exercised shall be correspondingly adjusted by the Grantor, and the Exercise Price shall be adjusted so that the product of the Exercise Price immediately after such event multiplied by the number of Option Shares subject to this Agreement immediately after such event shall be equal to the product of the Exercise Price multiplied by the number of Option Shares subject to this Agreement immediately prior to the occurrence of such event.
(b) In the event of a Sale Event, the unexercised portion of this Option shall be subject to Section 3(c) of the Plan.
(c) Any adjustment in the number of Option Shares shall apply proportionately to only the unexercised portion of the Option granted hereunder. If fractions of an Option Share would result from any such adjustment, the Grantor will not be required to issue such fractional Option Share but shall pay the Optionee in cash the value of such fractional Option Share.
10. Rights of Optionee.
The grant of the Option shall give the Optionee neither any right to similar grants nor any right to be retained in the employ of the Grantor, such employment being terminable to the same extent as if the Plan and this Agreement were not in effect. The right and power of the Grantor to dismiss or discharge any employee is specifically and unqualifiedly unimpaired by this Agreement. Neither the Optionee nor any other person legally entitled to exercise any rights under this Agreement shall be entitled to any of the rights or privileges of a stockholder of the Grantor with respect to any Option Shares which may be issuable upon any exercise pursuant to this Agreement, unless and until the stock records of the Grantor reflect the issuance of such Option Shares.
11. Notices.
Each notice or other communication relating to this Agreement shall be in writing and delivered in person or by registered mail to the Grantor at its office, 150 Commercial Street, Sunnyvale, California 94086, to the attention of the Chief Financial Officer. All notices to the Optionee or other person or persons then entitled to exercise any right pursuant to this Agreement shall be delivered to the Optionee or such other person or persons at the Optionee’s address specified in the introductory paragraph to this Agreement or at such other address as the Optionee or such other person may specify in writing to the Grantor by a notice delivered in accordance with this paragraph.
12. [Intentionally omitted.]
13. Binding Effect.
Except as herein otherwise expressly provided, this Agreement shall be binding upon and inure to the benefit of the parties hereto, their successors, legal representatives and assigns.
14. Agreement Subject to Plan.
Notwithstanding anything contained herein to the contrary, this Agreement is subject to, and shall be construed in accordance with, the terms of the Plan, which is incorporated by reference herein and made a part of this Agreement as if fully set forth herein. In the event of any inconsistency between the terms hereof and the terms of the Plan, the terms of the Plan shall govern.
15. Withholding.
Optionee agrees to cooperate with the Grantor to take all steps necessary or appropriate for the withholding of any applicable taxes by the Grantor under law or regulation in connection therewith. In the event the Optionee does not make the required withholding payment at the time of exercise, the Grantor may make such provisions and take such steps as it, in its sole discretion, may deem necessary or appropriate for the withholding of any taxes that the Grantor is required by any law or regulation of any governmental authority, whether federal, state or local, domestic or foreign, to withhold in connection with the exercise of any Option, including, but not limited to, (i) refusing to accept payment for the Option Shares until the Optionee reimburses the Grantor for the amount the Grantor is required to withhold with respect to such taxes, or (ii) canceling the number of Option Shares issuable upon exercise of the Option in an amount sufficient to reimburse the Grantor for the amount it is required to so withhold, and/or (iii) withholding the amount due from the Optionee’s wages if he is employed by the Grantor or any subsidiary thereof.
16. Miscellaneous.
This Agreement shall be construed under the laws of the State of California, without application to the principles of conflicts of laws. Headings have been included herein for convenience of reference only, and shall not be deemed a part of the Agreement.
IN WITNESS WHEREOF, the parties hereto have executed this Non-Qualified Stock Option Agreement as of the day and year first above written.
|
VIVEVE MEDICAL, INC.
By: Name: Title:
OPTIONEE
By:
Taxpayer Identification No.: |
LETTER OF STOCK OPTION EXERCISE
Dated _________ __, 201_
Viveve Medical, Inc.
150 Commercial Street
Sunnyvale, CA 94086
Attention: Chief Financial Officer
Ladies and Gentlemen:
I wish to purchase the following shares of common stock of Viveve Medical, Inc. pursuant to the non-qualified stock option granted to me on _________ __, 201__ under the Viveve Medical, Inc. 2013 Stock Option and Incentive Plan:
Number of Non-qualified Stock Option shares being purchased hereby (the “Shares”): ________________________________
The exercise price for the Shares is $___ per Share. My check payable to Viveve Medical, Inc. in the amount of $________ in payment of the purchase price is enclosed.* Please issue the stock certificate(s) for these Shares in my name as follows:
|
**Name
|
|
Address
|
Social Security Number
|
|
|
Sincerely yours, |
|
|
|
|
|
|
|
|
|
|
|
Signature |
|
Office Telephone/Home Telephone |
* |
If stock is used in payment, please contact the CFO of the Company. |
** |
If you wish to have the Shares issued in your name and that of another person jointly, we suggest that the following form be used: “(Your name) and (name of other person), as joint tenants with right of survivorship.” |
7
Exhibit 10.2
VIVEVE MEDICAL, INC.
2013 STOCK OPTION AND INCENTIVE PLAN
INCENTIVE STOCK OPTION AGREEMENT
This INCENTIVE STOCK OPTION AGREEMENT (the "Option Agreement"), dated as of the __ day of ___________, 201_ (the "Grant Date"), is between Viveve Medical, Inc. , a Yukon Territory corporation (the "Company"), and ___________________ (the "Optionee"), an employee or consultant of the Company or of a Subsidiary of the Company (a "Related Corporation"), pursuant to the Viveve Medical, Inc. 2013 Stock Option and Incentive Plan (also referred to as the PLC Systems, Inc. 2013 Stock Option and Incentive Plan), as amended (the "Plan").
WHEREAS, the Company desires to give the Optionee the opportunity to purchase shares of common stock of the Company, no par value per share ("Common Shares") in accordance with the provisions of this Agreement and the Plan, a copy of which is attached hereto;
NOW THEREFORE, in consideration of the mutual covenants hereinafter set forth and for other good and valuable consideration, the parties hereto, intending to be legally bound hereby, agree as follows:
1. Grant of Option. The Company hereby grants to the Optionee the right and option (the "Option") to purchase all or any part of an aggregate of ________________ Common Shares. The Option is in all respects limited and conditioned as hereinafter provided, and is subject in all respects to the terms and conditions of the Plan now in effect and as it may be amended from time to time (but only to the extent that such amendments apply to outstanding options). Such terms and conditions are incorporated herein by reference, made a part hereof, and shall control in the event of any conflict with any other terms of this Option Agreement. The Option granted hereunder is intended to be an incentive stock option ("ISO") meeting the requirements of the Plan and Section 422 of the Internal Revenue Code of 1986, as amended (the "Code"), and not a nonqualified stock option ("NQSO").
2. Exercise Price. The exercise price of the Common Shares covered by this Option shall be $______ per share. It is the determination of the committee administering the Plan (the "Committee") that on the Grant Date the exercise price was not less than the greater of (i) 100% (110% for an Optionee who owns more than 10% of the total combined voting power of all shares of stock of the Company or of a Related Corporation - a "More-Than-10% Owner") of the "Fair Market Value" (as defined in the Plan) of a Common Share, or (ii) the stated capital of a Common Share.
3. Term. Unless earlier terminated pursuant to any provision of the Plan or of this Option Agreement, this Option shall expire on ________________(the "Expiration Date"), which date is not more than 10 years (five [5] years in the case of a More- Than-10% Owner) from the Grant Date. This Option shall not be exercisable on or after the Expiration Date.
4. Exercise of Option. Subject to Sections 7-9 of this Option Agreement, the right to exercise this Option and purchase of the Common Shares shall vest in the following manner: at a rate of ______ Common Shares per each [month] of the Optionee’s continuous service to the Company.
5. Method of Exercising Option. Subject to the terms and conditions of this Option Agreement and the Plan, the Option may be exercised by written notice to the Company at its principal office. The form of such notice is attached hereto and shall state the election to exercise the Option and the number of whole shares with respect to which it is being exercised; shall be signed by the person or persons so exercising the Option; and shall be accompanied by payment of the full exercise price of such shares. No fractional shares shall be issued. Any fractional shares issuable upon the exercise of the Option shall be rounded down to the nearest whole share.
The exercise price shall be paid to the Company:
(a) in cash, or by certified check, bank draft, or postal or express money order;
(b) [through the delivery of Common Shares previously acquired by the Optionee];
(c) by delivering a properly executed notice of exercise of the Option to the Company and a broker, with irrevocable instructions to the broker promptly to deliver to the Company the amount necessary to pay the exercise price of the Option;
(d) in Common Shares newly acquired by the Optionee upon exercise of the Option (which shall constitute a disqualifying disposition with respect to this ISO); or
(e) in any combination of (a), (b), (c) or (d) above.
In the event the exercise price is paid, in whole or in part, with Common Shares, the portion of the exercise price so paid shall be equal to the Fair Market Value of the Common Shares surrendered on the date of exercise.
Upon receipt of notice of exercise and payment, the Company shall deliver a certificate or certificates representing the Common Shares with respect to which the Option is so exercised. The Optionee shall obtain the rights of a shareholder upon receipt of a certificate(s) representing such Common Shares.
Such certificate(s) shall be registered in the name of the person so exercising the Option (or, if the Option is exercised by the Optionee and if the Optionee so requests in the notice exercising the Option, shall be registered in the name of the Optionee and the Optionee's spouse, jointly, with right of survivorship), and shall be delivered as provided above to, or upon the written order of, the person exercising the Option. In the event the Option is exercised by any person after the death or disability (as determined in accordance with Section 22(e)(3) of the Code) of the Optionee, the notice shall be accompanied by appropriate proof of the right of such person to exercise the Option. All Common Shares that are purchased upon exercise of the Option as provided herein shall be fully paid and non-assessable.
Upon exercise of the Option, Optionee shall be responsible for all employment and income taxes then or thereafter due (whether Federal, State or local), and if the Optionee does not remit to the Company sufficient cash (or, with the consent of the Committee, Common Shares) to satisfy all applicable withholding requirements, the Company shall be entitled to satisfy any withholding requirements for any such tax by disposing of Common Shares at exercise, withholding cash from Optionee's salary or other compensation or such other means as the Committee considers appropriate to the fullest extent permitted by applicable law. Nothing in the preceding sentence shall impair or limit the Company's rights with respect to satisfying withholding obligations under Section 13 of the Plan.
6. Non-Transferability of Option. Except as specifically provided in Section 5(b) of the Plan and this Agreement, the Optionee may not give, grant, sell, exchange, transfer legal title, pledge, assign or otherwise encumber or dispose of the Option herein granted or any interest therein. Any attempt to transfer, assign, pledge or otherwise dispose of, or to subject to execution, attachment or similar process, the Option contrary to the provisions hereof shall be void and ineffective and shall give no right to the purported transferee.
7. Termination of Employment. If the Optionee's employment with the Company and all Related Corporations is terminated for any reason (other than death or disability, or for cause) prior to the Expiration Date, then this Option may be exercised by Optionee, to the extent of the number of Common Shares with respect to which the Optionee could have exercised it on the date of such termination of employment, at any time prior to the earlier of (i) the Expiration Date, or (ii) ninety days after such termination of employment. Any part of the Option that was not exercisable immediately before the termination of Optionee's employment shall terminate at that time. The Option shall not be exercisable by the Optionee following termination of the Optionee’s employment or service for cause. "Termination for cause" shall mean dismissal for dishonesty, conviction or confession of a crime punishable by law (except minor violations), fraud, misconduct or disclosure of confidential information. If the service of the Optionee shall be suspended pending an investigation of whether or not the Optionee shall be terminated for cause, all of the Optionee’s rights connected to the Option shall be suspended during the period of investigation.
8. Disability. If the Optionee becomes disabled (as determined in accordance with section 22(e)(3) of the Code) during his or her employment and, prior to the Expiration Date, the Optionee's employment is terminated as a consequence of such disability, then this Option may be exercised by the Optionee or by the Optionee's legal representative, to the extent of the number of Common Shares with respect to which the Optionee could have exercised it on the date of such termination of employment at any time prior to the earlier of (i) the Expiration Date or (ii) three hundred and sixty days after such termination of employment. Any part of the Option that was not exercisable immediately before the Optionee's termination of employment shall terminate at that time.
9. Death. If the Optionee dies during his or her employment and prior to the Expiration Date, or if the Optionee's employment is terminated for any reason (as described in Paragraphs 7 and 8) and the Optionee dies following his or her termination of employment but prior to the earliest of (i) the Expiration Date, or (ii) the expiration of the period determined under Paragraph 7 or 8 (as applicable to the Optionee), then this Option may be exercised by the Optionee's estate, personal representative or beneficiary who acquired the right to exercise this Option by bequest or inheritance or by reason of the Optionee's death, to the extent of the number of Common Shares with respect to which the Optionee could have exercised it on the date of his or her death, at any time prior to the earlier of (i) the Expiration Date or (ii) three hundred and sixty days after the date of the Optionee's death. Any part of the Option that was not exercisable immediately before the Optionee's death shall terminate at that time.
10. Disqualifying Disposition of Option Shares. The Optionee agrees to give written notice to the Company, at its principal office, if a "disposition" of the Common Shares acquired through exercise of the Option granted hereunder occurs at any time within two years after the Grant Date or within one year after the transfer to the Optionee of such shares. Optionee acknowledges that if such disposition occurs, the Optionee generally will recognize ordinary income as of the date the Option was exercised in an amount equal to the lesser of (i) the Fair Market Value of the Common Shares on the date of exercise minus the exercise price, or (ii) the amount realized on disposition of such shares minus the exercise price. If requested by the Company at the time of and in the case of any such disposition, Optionee shall pay to the Company an amount sufficient to satisfy the Company's federal, state and local withholding tax obligations with respect to such disposition. The provisions of this Section 10 shall apply, whether or not the Optionee is in the employ of the Company at the time of the relevant disposition. For purposes of this Paragraph, the term "disposition" shall have the meaning assigned to such term by section 424(c) of the Code.
11. Securities Matters. (a) If, at any time, counsel to the Company shall determine that the listing, registration or qualification of the Common Shares subject to the Option upon any securities exchange or under any state or federal law, or the consent or approval of any governmental or regulatory body, or that the disclosure of non-public information or the satisfaction of any other condition is necessary as a condition of, or in connection with, the issuance or purchase of Common Shares hereunder, such Option may not be exercised, in whole or in part, unless such listing, registration, qualification, consent or approval, or satisfaction of such condition shall have been effected or obtained on conditions acceptable to the Board of Directors. The Company shall be under no obligation to apply for or to obtain such listing, registration or qualification, or to satisfy such condition. The Committee shall inform the Optionee in writing of any decision to defer or prohibit the exercise of an Option. During the period that the effectiveness of the exercise of an Option has been deferred or prohibited, the Optionee may, by written notice, withdraw the Optionee's decision to exercise and obtain a refund of any amount paid with respect thereto.
(b) The Company may require: (i) the Optionee (or any other person exercising the Option in the case of the Optionee's death or Disability) as a condition of exercising the Option, to give written assurances, in substance and form satisfactory to the Company, to the effect that such person is acquiring the Common Shares subject to the Option for his or her own account for investment and not with any present intention of selling or otherwise distributing the same, and to make such other representations or covenants; and (ii) that any certificates for Common Shares delivered in connection with the exercise of the Option bear such legends, in each case as the Company deems necessary or appropriate, in order to comply with federal and applicable state securities laws, to comply with covenants or representations made by the Company in connection with any public offering of its Common Shares or otherwise. The Optionee specifically understands and agrees that the Common Shares, if and when issued upon exercise of the Option, may be "restricted securities," as that term is defined in Rule 144 under the Securities Act of 1933 and, accordingly, the Optionee may be required to hold the shares indefinitely unless they are registered under such Securities Act of 1933, as amended, or an exemption from such registration is available.
(c) The Optionee shall have no rights as a shareholder with respect to any Common Shares covered by the Option (including, without limitation, any rights to receive dividends or non-cash distributions with respect to such shares) until the date of issue of a stock certificate to the Optionee for such Common Shares. No adjustment shall be made for dividends or other rights for which the record date is prior to the date such stock certificate is issued.
12. Governing Law. This Option Agreement shall be governed by the applicable Code provisions to the maximum extent possible. Otherwise, the laws of the State of California (without reference to the principles of conflict of laws) shall govern the operation of, and the rights of the Optionee under, the Plan and Options granted thereunder.
[SIGNATURE PAGE FOLLOWS]
IN WITNESS WHEREOF , the parties hereto have duly executed this Incentive Stock Option Agreement as of the _________day of __________, 201_.
|
VIVEVE MEDICAL, INC.
By: ___________________________ Name: Title:
___________________________ Optionee: |
VIVEVE MEDICAL, INC.
2013 STOCK OPTION AND INCENTIVE PLAN
Notice of Exercise of Incentive Stock Option
I hereby exercise the incentive stock option granted to me pursuant to the Incentive Stock Option Agreement dated as of ______________, by Viveve Medical, Inc. (the "Company"), with respect to the following number of shares of the Company's common stock ("Shares"), no par value per Share, covered by said option:
Number of Shares to be purchased: __________
Purchase price per Share: $ _________
Total purchase price: $ _________
_____ A. |
Enclosed is cash or my certified check, bank draft, or postal or express money order in the amount of $______ in full/partial [circle one] payment for such Shares; |
and/or
_____ B. |
Enclosed is/are _____ Share(s) with a total fair market value of $_________ on the date hereof in full/partial [circle one] payment for such Shares; |
and/or
_____ C. |
I have provided notice to ___________________ [insert name of broker ], a broker, who will render full/partial [circle one] payment for such Shares. [Optionee should attach to the notice of exercise provided to such broker a copy of this Notice of Exercise and irrevocable instructions to pay to the Company the full/partial (a s elected above) exercise price ] ; |
and/or
_____ D. |
I elect to satisfy the payment for Shares purchased hereunder by having the Company withhold newly acquired Shares pursuant to the exercise of the Option. I understand that this will result in a "disqualifying disposition" as described in Section 10 of my Incentive Stock Option Agreement. |
Please have the certificate or certificates representing the purchased Shares registered in the following
name or names*:__________________________________; and sent to:
________________________________________________________________________.
DATED: ____________ ___, 20___
|
|
|
|
|
|
Optionee's Signature |
|
___________________
* Certificates may be registered in the name of the Optionee alone or in the joint names (with right of survivorship) of the Optionee and his or her spouse.
-8-
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in this Registration Statement on Form S-8 of our report (which contains an explanatory paragraph relating to the Company’s ability to continue as a going concern as described in Note 1 to the financial statements) dated March 18, 2014 relating to the financial statements of Viveve, Inc., which appears in the Definitive Proxy Statement on Schedule 14A of PLC Systems Inc. filed on August 11, 2014 and incorporated by reference in the Current Report on Form 8-K/A of Viveve Medical, Inc. (formerly PLC Systems Inc.).
/s/ Burr Pilger Mayer, Inc.
San Jose, California
January 16, 2015
Exhibit 23.2
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statement on Form S-8 of Viveve Medical, Inc. of our report dated March 31, 2014, relating to our audit of the financial statements, which appear in the Annual Report on Form 10-K of Viveve Medical, Inc. (formerly PLC Systems, Inc.) for the year ended December 31, 2013.
/s/ McGladrey LLP
Boston, Massachusetts
January 16, 2015
Exhibit 24.1
THE VIVEVE MEDICAL, INC.
REGISTRATION STATEMENT ON FORM S-8
POWER OF ATTORNEY
Each undersigned officer and/or director of Viveve Medical, Inc., a Yukon Territory corporation (the "Registrant"), does hereby make, constitute and appoint Patricia Scheller, Chief Executive Officer of the Registrant, and Scott Durbin, Chief Financial Officer of the Registrant, and any other person holding the position of Chief Executive Officer or Chief Financial Officer of the Registrant from time to time, and each of them, as attorney-in-fact and agents of the undersigned, each with full power of substitution and resubstitution, with the full power to execute and file:
(i) |
the Registration Statement on Form S-8 (the "Form S-8 Registration Statement") with respect to the registration under the Securities Act of 1933, as amended, of common stock, no par value, of the Registrant issuable in connection with The Viveve Medical, Inc. 2013 Stock Option and Incentive Plan, as amended (the "Plan"), as may be revised in accordance with the Company resolution entitled "Authorize Filing of S-8 Registration Statement for The Viveve Medical, Inc. 2013 Stock Option and Incentive Plan" along with an indeterminate amount of interests to be offered or sold pursuant to the Plan; |
(ii) |
any and all amendments, including post-effective amendments, and exhibits to the Form S-8 Registration Statement; and |
(iii) |
any and all applications or other documents to be filed with the Securities and Exchange Commission or any state securities commission or other regulatory authority with respect to the securities covered by the Form S-8 Registration Statement, with full power and authority to do and perform any and all acts and things whatsoever necessary, appropriate or desirable to be done in the premises, or in the name, place and stead of the said director and/or officer, hereby ratifying and approving the acts of said attorney. |
[ Signature page follows ]
IN WITNESS WHEREOF, the undersigned have subscribed to the above as of November 21, 2014.
Signature |
|
Title |
|
|
|
/s/ Patricia Scheller |
|
Chief Executive Officer (Principal Executive Officer) and Director |
Patricia Scheller |
|
|
/s/ Scott Durbin |
|
Chief Financial Officer (Principal Financial Officer) |
Scott Durbin |
|
|
|
|
|
/s/ Brigitte Smith |
|
Chairman of the Board |
Brigitte Smith |
|
|
|
|
|
/s/ Mark Colella |
|
Director |
Mark Colella |
|
|
|
|
|
/s/ Carl Simpson |
|
Director |
Carl Simpson |
|
|
|
|
|
/s/ Daniel Janney |
|
Director |
Daniel Janney |
|
|
|
|
|